Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000003

Options or other derivatives

  • Chief Scientific Officer acquired 57,318 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Car Bruce · Chief Scientific Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-01-06 Grant or award : show line 1 in the form Stock option (right to buy) +47,007 47,007 D
2020-01-06 Grant or award : show line 2 in the form Restricted stock units +10,311 10,311 D
Loading xslF345X03/wf-form4_157851867389419.xml…